Literature DB >> 29093007

miR-519d Promotes Melanoma Progression by Downregulating EphA4.

Kuo-Tai Hua1, Jin-Bong Hong2, Yi-Shuan Sheen2, Hsin-Yi Huang3, Yi-Ling Huang2, Jau-Shiuh Chen2, Yi-Hua Liao4.   

Abstract

Increasing evidence suggests that there is a unique cell subpopulation in melanoma that can form nonadherent melanospheres in serum-free stem cell medium, mimicking aggressive malignancy. Using melanospheres as a model to investigate progression mechanisms, we found that miR-519d overexpression was sufficient to promote cell proliferation, migration, invasion, and adhesion in vitro and lung metastatic capability in vivo The cell adhesion receptor EphA4 was determined to be a direct target of miR-519d. Forced expression of EphA4 reversed the effects of miR-519d overexpression, whereas silencing of EphA4 phenocopied the effect of miR-519d. Malignant progression phenotypes were also affected at the level of epithelial-to-mesenchymal transition and the ERK1/2 signaling pathway inversely affected by miR-519d or EphA4 expression. In clinical specimens of metastatic melanoma, we observed significant upregulation of miR-519d and downregulation of EphA4, in the latter case correlated inversely with overall survival. Taken together, our results suggest a significant functional role for miR-519d in determining EphA4 expression and melanoma progression.Significance: These results suggest a significant role for miR-519d in determining expression of a pivotal cell adhesion molecule that may impact risks of malignant progression in many cancers. Cancer Res; 78(1); 216-29. ©2017 AACR. ©2017 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29093007     DOI: 10.1158/0008-5472.CAN-17-1933

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  8 in total

1.  [Over-expression of miR-519d alters gene expression profiles of cervical cancer SiHa cells].

Authors:  Ye Zeng; Jie Liu; Zhichao Cheng; Sirong Zheng; Hanrong Zhang; Jueyu Zhou
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2018-07-30

Review 2.  MicroRNA Signature in Melanoma: Biomarkers and Therapeutic Targets.

Authors:  Soudeh Ghafouri-Fard; Mahdi Gholipour; Mohammad Taheri
Journal:  Front Oncol       Date:  2021-04-22       Impact factor: 6.244

3.  Nonadherent culture method promotes MSC-mediated vascularization in myocardial infarction via miR-519d/VEGFA pathway.

Authors:  Baoping Deng; Xianlan Zhang; Yi Liang; Haiming Jiang; Weizhao Huang; Yinmeng Wu; Weiping Deng
Journal:  Stem Cell Res Ther       Date:  2020-07-02       Impact factor: 6.832

4.  miR-491-5p functions as a tumor suppressor by targeting IGF2 in colorectal cancer.

Authors:  Lei Lu; Ming Cai; Meixia Peng; Fei Wang; Xiaofeng Zhai
Journal:  Cancer Manag Res       Date:  2019-02-22       Impact factor: 3.989

Review 5.  The miRNAs Role in Melanoma and in Its Resistance to Therapy.

Authors:  Francesca Varrone; Emilia Caputo
Journal:  Int J Mol Sci       Date:  2020-01-29       Impact factor: 5.923

6.  Exosomal miR-106b-5p derived from melanoma cell promotes primary melanocytes epithelial-mesenchymal transition through targeting EphA4.

Authors:  Wenkang Luan; Yuting Ding; Haolan Xi; Hongru Ruan; Feng Lu; Shaojun Ma; Jinlong Wang
Journal:  J Exp Clin Cancer Res       Date:  2021-03-19

7.  New stem cell autophagy surrogate diagnostic biomarkers in early-stage hepatocellular carcinoma in Egypt: A pilot study.

Authors:  Tarek Yosef; Wesam Ahmed Ibrahim; Marwa Matboli; Amina Ahmed Swilam; Sarah El-Nakeep
Journal:  World J Hepatol       Date:  2021-12-27

8.  miR-1236-3p inhibits invasion and metastasis in gastric cancer by targeting MTA2.

Authors:  Jia-Xiang An; Ming-Hui Ma; Chun-Dong Zhang; Shuai Shao; Nuo-Ming Zhou; Dong-Qiu Dai
Journal:  Cancer Cell Int       Date:  2018-05-01       Impact factor: 5.722

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.